BullFrog AI Holdings, Inc. (BFRG)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$5.2M
Cash & Equivalents
$1.7M
Quarterly Burn Rate
9 mo
Est. Cash Runway
$12M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (2)

NCT #TitlePhaseStatusEnrollment
NCT04862468 Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute F... PHASE2 Recruiting 80
NCT04858776 Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacut... PHASE2 Recruiting 60

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for BFRG.

SEC EDGAR Filings

All SEC filings for BullFrog AI Holdings, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.